Applied precision medicine in metastatic pancreatic ductal adenocarcinoma

BACKGROUND: Metastatic pancreatic ductal adenocarcinoma (mPDAC) bears a dismal prognosis due to the limited activity of systemic chemotherapy. In our platform for precision medicine, we aim to offer molecular-guided treatments to patients without further standard therapy options. METHODS: In this si...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Med Oncol
Asıl Yazarlar: Taghizadeh, Hossein, Müllauer, Leonhard, Mader, Robert M., Schindl, Martin, Prager, Gerald W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7357054/
https://ncbi.nlm.nih.gov/pubmed/32699558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920938611
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller